115 related articles for article (PubMed ID: 32382335)
1. Survivin expression as an independent predictor of overall survival in malignant peritoneal mesothelioma.
Zhang G; Yang DL; Zheng G; Liang Y
Oncol Lett; 2020 Jun; 19(6):3871-3880. PubMed ID: 32382335
[TBL] [Abstract][Full Text] [Related]
2. IMP3 as a prognostic biomarker in patients with malignant peritoneal mesothelioma.
Hui S; Guo-Qi Z; Xiao-Zhong G; Chun-Rong L; Yu-Fei L; Dong-Liang Y
Hum Pathol; 2018 Nov; 81():138-147. PubMed ID: 30031101
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of CD74, CD10 and Ki-67 immunohistochemical expression in patients with diffuse malignant peritoneal mesothelioma: a retrospective study.
Liang Y; Li C; Liu Y; Tian L; Yang D
BMC Cancer; 2023 May; 23(1):406. PubMed ID: 37147569
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin, GLUT1 and Ki-67 expression in malignant peritoneal mesothelioma: prognostic implications.
Liu Y; Zheng G; Yang D; Guo X; Tian L; Song H; Liang Y
Intern Med J; 2021 Jun; 51(6):896-904. PubMed ID: 32510678
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic value of new TNM staging and serum CA125 in malignant peritoneal mesothelioma].
Wei F; Zheng GQ; Song H; Liang YF; Yin WJ; Sun NN; Yang YX
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2020 May; 38(5):321-326. PubMed ID: 32536066
[No Abstract] [Full Text] [Related]
6. Is survivin expression prognostic or predictive in malignant pleural mesothelioma?
Hmeljak J; Erčulj N; Dolžan V; Pižem J; Kern I; Kovač V; Cemažar M; Cör A
Virchows Arch; 2013 Mar; 462(3):315-21. PubMed ID: 23358691
[TBL] [Abstract][Full Text] [Related]
7. Significance of EGFR and PTEN Expression and PLR and NLR for Predicting the Prognosis of Epithelioid Malignant Peritoneal Mesothelioma.
Liang Y; Zheng G; Yin W; Song H; Li C; Tian L; Yang D
Gastroenterol Res Pract; 2019; 2019():7103915. PubMed ID: 30863440
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment Controlling Nutritional Status Score and Lactate Dehydrogenase as Predictive Markers of Survival in Patients with Malignant Peritoneal Mesothelioma.
Wang QQ; Zheng GQ; Yang DL; Liang YF; Yin WJ; Su SS
Nutr Cancer; 2018; 70(8):1264-1274. PubMed ID: 30663400
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of survivin in breast cancer: meta-analysis.
Li Y; Ma X; Wu X; Liu X; Liu L
Breast J; 2014; 20(5):514-24. PubMed ID: 25041354
[TBL] [Abstract][Full Text] [Related]
10. [Pathological classification of malignant peritoneal mesothelioma and comparative analysis with peritoneal carcinomatosis].
Zhang GZ; Zheng GQ; Wei F; Liu YY; Song H; Liang YF
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Jul; 41(7):541-546. PubMed ID: 37524680
[No Abstract] [Full Text] [Related]
11. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
[TBL] [Abstract][Full Text] [Related]
12. Nomogram Based on Systemic Immune-Inflammation Index to Predict Survival of Tongue Cancer Patients Who Underwent Cervical Dissection.
Lu Z; Yan W; Liang J; Yu M; Liu J; Hao J; Wan Q; Liu J; Luo C; Chen Y
Front Oncol; 2020; 10():341. PubMed ID: 32219070
[No Abstract] [Full Text] [Related]
13. Prognostic role of radiological peritoneal cancer index in malignant peritoneal mesothelioma: national cohort study.
Salo SAS; Lantto E; Robinson E; Myllärniemi M; Laaksonen S; Salo JA; Rantanen T; Ilonen I
Sci Rep; 2020 Aug; 10(1):13257. PubMed ID: 32764701
[TBL] [Abstract][Full Text] [Related]
14. Forecast of Malignant Peritoneal Mesothelioma Mortality in Italy up to 2040.
Oddone E; Bollon J; Nava CR; Minelli G; Imbriani M; Consonni D; Marinaccio A; Magnani C; Barone-Adesi F
Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33379304
[TBL] [Abstract][Full Text] [Related]
15. A Histomorphologic Grading System That Predicts Overall Survival in Diffuse Malignant Peritoneal Mesothelioma With Epithelioid Subtype.
Valente K; Blackham AU; Levine E; Russell G; Votanopoulos KI; Stewart JH; Shen P; Geisinger KR; Sirintrapun SJ
Am J Surg Pathol; 2016 Sep; 40(9):1243-8. PubMed ID: 27438989
[TBL] [Abstract][Full Text] [Related]
16. Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.
He CB; Lao XM; Lin XJ
Chin J Cancer; 2017 Jul; 36(1):59. PubMed ID: 28728568
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of nomogram based on pre-treatment inflammatory markers in patients with pulmonary-only synchronous metastases from colorectal cancer.
Chen L; Li Q; Wang Y; Yang J; Ma X
Int Immunopharmacol; 2019 Dec; 77():106001. PubMed ID: 31734191
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of Blood, Serum, and Ascites Parameters in Patients with Malignant Peritoneal Mesothelioma or Peritoneal Carcinomatosis.
Su SS; Zheng GQ; Yin WJ; Liang YF; Liu YY; Song H; Sun NN; Yang YX
Gastroenterol Res Pract; 2018; 2018():2619526. PubMed ID: 29643915
[TBL] [Abstract][Full Text] [Related]
19. Serum Survivin Levels and Outcome of Chemotherapy in Patients with Malignant Mesothelioma.
Goričar K; Kovač V; Franko A; Dodič-Fikfak M; Dolžan V
Dis Markers; 2015; 2015():316739. PubMed ID: 26451067
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients.
Chen P; Li J; Ge LP; Dai CH; Li XQ
Respirology; 2010 Apr; 15(3):501-9. PubMed ID: 20210890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
